E-Commerce a Big Part of Honey Birdette’s Growth:

Honey Birdette, the Australian based sensuality boutique, is embarking on a major growth project. Part of its expansion plan is for the online realm. The company is setting up an exclusive e-commerce site for U.S. customers. The move comes after Honey Birdette officials reported a whopping 374 percent increase in online sales by customers in America within the past year. The new site promises faster delivery, more products for U.S. customers, and free delivery for orders over 50 dollars.

Honey Birdette also plans to have more of a brick and mortar presence outside its native Australia. The company plans to open several outlets in the United States in the near future. In Britain, where Honey Birdette established its first overseas store in London’s Convent Garden, plans are in the works for 40 stores in that country by the end of 2018. Locations for these new stores include Leeds, Newcastle, and Liverpool. More expansion is also planned for Continental Europe. The company specializes in lingerie, but sells various other sensual products.

Honey Birdette was founded in Brisbane in 2006 by Eloise Monaghan. The idea for the store came to her when she went shopping in an adult store for a present for a bachelorette party. Upon seeing the business selling pornographic DVDs and sex toys more oriented toward men, Monaghan decided women deserve a better store to make them feel comfortable with their sexuality. Her store really took off after entering into a partnership with billionaire retailer Brett Blundy.

Honey Birdette operates 55 stores throughout Australia. At present, there are three Honey Birdette locations in the United Kingdom. As mentioned previously, that number will increase significantly in the coming year.

See more Honeys on Instagram.

The Academic Achievements Of Dr. Cameron Clokie

Dr. Cameron Clokie is an oral and maxillofacial surgeon. Besides, he is a scientist as well as a serial entrepreneur. Currently, Dr. Cameron Clokie is the CEO of Induce Biologics Inc. This is a medicine company that provides innovative solutions that can aid in musculoskeletal reconstruction.

He has an experience of over three decades in academic dentistry practice. It was in 1998 that Dr. Cameron Clokie was named as the Head of Oral and Maxillofacial Surgery. This was at the University of Toronto. Post that he was appointed as the Professor of Oral and Maxillofacial Surgery at the same University. He retires from academics in 2017. In addition, Dr. Cameron Clokie has held positions on the scientific advisory boards of a number of companies.

Cameron Clokie is also known for the papers published by him and his presentations. He is renowned nationally as well as internationally for his knowledge and experience on bone reconstruction as well as on regenerative medicine.

Dr. Cameron Clokie holds nearly 25 US as well as international patents. Some are existing, while others may be pending. All of these are related to healing of bones. This way he has managed to develop a strategic alliance with several businesses. In this way, he is able to transfer his knowledge as well as ingenuity into enterprises that are commercially viable.

Dr. Cameron Clokie is heading the Oral and Maxillofacial Surgery at the University of Toronto. He is the pioneer of a technique in which eight patients have undergone a bone regeneration method in Canada. This can revolutionize reconstructive surgery today.

He is using a protein that can turn adult stem cells into bone tissue. This way he is able to make bones grow.

He says that it is still in an early stage. This can help to regrow a bone that may have been lost due to accident or some other condition.

He has performed certain procedures at Toronto General Hospital and Mount Sinai Hospital. These can be considered as a milestone for tissue regeneration. Typically current ways of rebuilding any body parts make use of a painful process of using bone or muscle from one area and filling the gap somewhere else.

Clay Siegall blazes trails in exciting new field of targeted cancer therapies

Today we take for granted that the medical establishment is fully capable of treating many types of cancers, improving survivability at the five-year benchmark to almost 100 percent, with many types of cancers. Far from a pedestrian accomplishment, this is a quite remarkable achievement, one that humanity lived without for the first 200,000 years of its existence.

It wasn’t until the 1930s that cancer really even became treatable. Before that, surgeries were occasionally done in an attempt to excise tumors, but these often had dismal results, with the patient being about as likely to die from the intervention as they were from the cancer itself.

However, that began to change with the advent of radiation therapy, as well as chemotherapy. But these treatments had absolutely brutal side effects, often leaving the patient with permanent paresthesia, sensory deficits and even dementia. Still, five-year survival rates for a wide array of cancer types did begin to dramatically improve and continued to do so throughout the ‘50s and ‘60s.

But then, the cancer treatment field began running into a period of stagnation. Most of the low-hanging fruit, the dramatic improvement in survival rates, was already harvested. The cancer treatment industry needed to find new methods to continue making significant strides in the five-year survival rates for most types of cancer.

Then along came Clay Siegall, a researcher for Bristol-Myers Squibb in the area of targeted drugs. In 1998, Dr. Siegall founded Seattle Genetics, a company dedicated to the research and development of a class of targeted cancer therapy called antibody drug conjugates. The principle behind antibody drug conjugates is simple enough. They use the body’s own immune system to target malignant growths and then bombard them with cytotoxic agents. The difference between this class of drugs and traditional chemotherapy is that, at least in theory, antibody drug conjugates can completely eliminate the systemic release of highly lethal and dangerous chemotherapeutic agents.

With antibody drug conjugates, a cytotoxic agent is chemically bound to the antibody, only being released upon direct contact with or ingestion into the tumor tissue. This dramatically increases the therapeutic window, that is, the amount of a drug that can be given at any one time. This allows for amounts of cytotoxic chemicals to be pumped into the tumor site that will kill all malignant tissue with almost total certainty.

What Makes Richard Mishaan So Special?

As an interior designer, it is their job to give create the perfect space for a client. Mixing together styles and bringing design to life is a rare talent that so few designers have. One designer who has this talent is Richard Mishaan. Richard Mishaan has spent over 20 years designing beautiful homes for people and does so in an original way.


What makes Richard Mishaans style so unique is his uncanny ability to seamlessly connect pieces to pieces that do not match in style. He takes pieces separated by centuries and puts them into a design that makes them look perfect together. This rare ability is something many can try to replicate, but so few can do well.


Besides his ability to combine objects together, he is also a fan of using colors. In a time where so many have gone monochrome, Richard Mishaan is not afraid to add bold colors to rooms and designs. Even with his bolder choice in colors, his designs are classic and ones that people can enjoy for years. His talent of creating colorful designs that still have a timeless look is something that many people are drawn to.


Based in New York, Richard Mishaan spends most of his designing time in New York City. As it is known that New York City is home to many wealthy people, most of his clients are looking for a more luxurious design. With his talents, he has been able to deliver luxurious designs to people for the past couple of decades.


Richard Mishaan’s style is clearly shown in his books, especially “Artfully Modern.” In that book, people can get a close view of his own homes and how he brings his style to life in his amazing designs. Richard Mishaan was born in Columbia and attributes that to his unique and highly sight after style.


Richard Mishaan Design is a unique interior design firm that delivers clients a unique design that is simple and rare at the same time. His use of colors and eye-catching pieces is something that he does in such a beautiful way that it could pass as an art form.


Securus Technologies – Providing Reliable and Affordable Law Enforcement Services

The field of prison communication and criminal justice technology is getting crowded with many new companies surfacing now and then. However, one of the companies that have achieved remarkable success in a very short period is Securus Technologies. Securus Technologies offer a wide variety of services to the inmates as well as the law enforcement agencies. The law enforcement agencies are able to perform more efficiently and safely in the field with the services offered by Securus Technologies.


The company’s focus is to offer reliable and affordable inmate communication services to the detainees and prisoners, and it does so with the use of advanced technology. Securus Technologies has so far invested over $600 million into research and development alone to make sure that the products and services offered to the end users are high performance oriented and useful. The company recently launched the new video visitation service that enables the family of the prisoners to meet their loved one in prison with the help of video services. It saves the money of the family to travel all the way to the prison facility and also helps in meeting virtually more often.


Securus Technologies to promote transparency recently released a press release online. The press release showcased how the services of the company are effective in keeping the crime rate low and equip the law enforcement officials with the latest technology that keeps them and the community safe.


Many different services are launched by Securus Technologies from time to time. It helps the law enforcement agencies as well as the inmate communication field tremendously. I work with the police authority and have used the services offered by Securus on many occasions. It has helped me get the information I needed to respond quickly and catch the drug peddler inside the prison space. I hope the company continues to develop and invent new services for the law enforcement agencies.



Take an Eco-Friendly Trip

There are many great destinations to travel to when it comes to eco-friendly and conservation centered retreats.


Kenya is a good choice if you are going for an eco-conscious getaway. You will be able to view wildlife in an educational way and Kenya is known for being a leader in ecotourism. Kenya began to ban plastic bags in 2017 and there are even tours available that are helping women to gain new skills.


Bhutan is another adventure that you don’t want to miss. Bhutan is the first country to be carbon-neutral in the world. The forests of Bhutan effectively capture carbon and this area is known for its cultural preservation as well as its socioeconomic development.


British Columbia is sustainability focused and is where you can enjoy nature at its finest, from its sea lions to its migrating salmon. Great Bear Rainforest is well-known for its sustainability initiatives such as its water turbine energy system that provides a renewable energy sources. There are many adventure trips available so you can choose your favorite.


If you’re looking for something a little more exotic yet still eco-friendly, then the Galapagos is the place for you. The Galapagos is a very diverse ecosystem where you can see sea lions, giant tortoises, and birds. You can also visit the Charles Darwin Research Station to learn more about the endangered species in the area. There are many outfitters in the area that offer eco-excursions of the area and many are community-driven. The Planeterra Foundation is a nonprofit project that teaches Floeana Island residents management training and also supports wildlife preservation.


Wild Ark was created by very passionate conservationists committed to preserving the wild for our future generations and educating people about the wild. Wild Ark was founded by Mark and Sophie Hutchinson who are actively working on making a difference in the world.


Wild Ark has a mission to protect the biodiversity of the various green belts around the world and conserving wildlife. Wild Ark is also researching and creating opportunities for people to not only become inspired by nature, but to also protect it.


Visit http://wildark.com/ for more details.

Eric Lefkofsky-The CEO and Co-Founder of Tempus Is Bringing a New Approach to the Treatment of Cancer

There is no doubt that a huge percentage of people nowadays are succumbing to cancer-related complications. Although there have been tremendous efforts by researchers and scientists to bring this menace to a halt, still there are gaps that need to be filled. According to Eric Lefkofsky, the CEO and the co-founder of Tempus, there is the lack of adequate data that is required by doctors to treat various types of cancer successfully. Speaking at the Fortune Brainstorm Health Conference held in San Diego, Erick said that what is missing is a source to combine genomic data with therapeutic data.

According to Erick, researchers strive to collect only one type of data, which has not borne significant fruits in the fight against cancer. He continued to say that, gathering molecular data is not enough, researchers also need clinical, therapeutic and outcome response data. Therefore, it means that besides knowing about the patient’s RNA and DNA information, clinicians should strive to know which treatments the patients are taking and how they are responding to it.For instance, if one is doing research on a group of breast cancer patients receiving Herceptin, then they should be in a position to explain why it works on say 40% and not on 60% of the patients. The researcher should be able to explain what is going on with the patients who are not responding to the treatment. Eric Lefkofsky gave a case scenario where if a researcher went to any cancer center and requested data of patients who underwent Herceptin treatment, they would need a grant and at least three months to access the information. He said that there should be a free flow of data between clinicians, researchers, and other people engaging in the fight against cancer.

About Tempus

Tempus is a technology firm that has built an operating system to fight cancer. Eric Lefkofsky is the CEO and co-founder of Tempus. He has co-founded other companies such as the Lightbank. Lightbank is a venture fund that has invested in disruptive technologies. After creating a successful empire, Eric Lefkofsky decided to give back to the society where he served through his Family Foundation, which he launched in 2006. Through his devotion to serving humanity, Eric Lefkofsky has been tasked with high-ranking positions in the Society where he serves as the Chairman and a Trustee of the board for several organizations.

Eric Lefkofsky Just Wants To Help The World

Doctors in today’s world are fully capable of managing cancer, the main issue is keeping doctors up to date with the correct data. Whether it is modernizing treatment options or keeping up to speed on patient records, the medical industry would flourish if the exchange of data had become more efficient.Eric Lefkofsky is the founder of Tempus, the ultimate database solution that will keep medical professionals in touch with the modern perspective of cancer treatments. Patient data may be combined within their system to determine genetic predisposition to cancer formation.Clinical data is highly valuable, but the truth about our knowledge about cancer will not come out without content data from the patient response. The medical industry is still purely based on theoretics and positive speculation at best. Eric’s theory is that patients may have different responses to treatments based on their genetics. Billions of dollars in chemotherapy and other reactionary treatments are going to waste for some people.

Herceptin is the most common medication that is initially used for breast cancer patients. The issue is that it only works for 40% of women and the research team is still clueless as for why it has that success rate. Other health factors may come into play, but the medical industry rarely takes note of the seemingly subtle details.Eric Lefkofsky is a well-rounded entrepreneur with a deep background in the technology industry. He is the co-founder of one of the biggest e-commerce marketplaces, Groupon. He is also the founder of the venture capital firm Lightbank. With all of his ventures, he now has a net worth of nearly $2 billion.

Eric is also running multiple charitable organizations. The Lefkofsky Foundation branches out into multiple fields including education, medical research, cultural enrichment and more. The organization is run by both him and his wife. They are also active contributors to The Giving Pledge. TGP is an organization made up of millionaires and billions that have signed agreements to give the majority of their wealth to select charitable organizations. Eric is just a tiny fraction of the cause since the entire fund is worth $365 billion.

The Wessex Institute of Technology Is The Center of Scientific Reasearch

The Wessex Institute of technology is located at the entrance of the New Forest National Park. This park had been used as a private hunting ground for many generations of royalty before becoming a national park. The greenery, wildlife and rural villages cover the majority of the area. The institute stands out as the most unique and significant location within the area.

The organization is known for their research programs with other European universities. Universita di Siena, Universidad de Granada and the University of the West of England are some of their notable partners. Many private and public organizations fund their research.

The institute also has a very popular publishing project known as the WITPress. They have opened up over 30,000 reasearch papers for public viewing. Anybody can go to the WITPress page and search through the papers to find what they need. They may also download the documents as a PDF file for free.


Alexandre Gama Finds Success In The Brazilian Advertising Industry

In 1982 the Brazilian advertising industry saw the arrival of one of its brightest stars when Alexandre Gama arrived as a writer at the Standard & Ogilvy agency; Gama would go on to work with some of the best advertising agencies in the country as he began a career that would lead the Rio de Janeiro born creative to the very top of the global marketing industry. Alexandre Gama set out on his own with the establishment of his Neogama ad agency in 1999 that was quickly rewarded for some fine work with a Golden lion at Cannes in its first year in operation. Neogama became a global force in advertising when a partnership was created with the London based BBH brand that allowed Alexandre Gama to take the skills he has developed in Brazil to London and beyond and continue his career on the largest possible scale.

See:  https://pt.wikipedia.org/wiki/Alexandre_Gama_(publicit%C3%A1rio)